David Reeser is one of the millions of Americans whose life has been changed by the ever-evolving, fast-growing epidemic of ...

Charles E. Hamner, Jr., Pd.D., the second president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...

Nipro Medical Corp., a medical equipment company based in Osaka, Japan, plans to invest $397.8 million to develop a new manufacturing facility and create more than 232 jobs in Greenville, N.C., one of ...

A buyout announcement today from Morrisville medical imaging company Bioptigen is the latest evidence that support from the North Carolina Biotechnology Center can be important. The 2004 Duke ...

The Triangle is known as a hotbed for innovation, thanks in large part to the partnerships between multiple stakeholders, including universities, investors and ecosystem support organizations. In that ...

Research Triangle Park-based Opus Genetics, a clinical-stage gene therapy company devoted to treating inherited retinal diseases, has been acquired by a small ophthalmic biopharmaceutical firm with ...

Entrepreneur & Pioneer. Drug hunter: 40 drugs in clinical development, Neurology/Psychiatry, HRT and Cancer, 3 marketed. 14 y in Biotech. 23y in Pharma, 6y in Academia. Business streamlining and ...

With over two decades of expertise in launching, scaling, and managing businesses across diverse sectors, I am a seasoned entrepreneur and financial services industry leader. Currently, I hold the ...

Pharmaron is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, ...

Business development, executive management, preclinical and clinical development, pharmaceuticals, neuroscience; Former President, NeuroGate.

Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, ...

Locus Biosciences is a fast-emerging North Carolina biotechnology company that’s about to get a lot faster at unfolding its Pac-Man-like genetic tricks to whack drug-resistant bacteria. The Research ...